HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wakamatsu, N. Articles by Katunuma, N. Search for Related Content PubMed PubMed Citation Articles by Wakamatsu, N. Articles by Katunuma, N. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 259, Issue 22, 13832-13838, Nov, 1984

Three forms of thiol proteinase inhibitor from rat liver formed depending on the oxidation-reduction state of a sulfhydryl group

N Wakamatsu, E Kominami, K Takio and N Katunuma

Three forms of a thiol proteinase inhibitor were isolated from rat liver cytosol. The monomeric inhibitor (pI 5.2) (TPI-1) formed a complex with cathepsin H even in the absence of reducing agents. The inhibitor with pI 5.0 (TPI-2) was inactive in the absence of reducing agents but was converted to an active inhibitor on addition of reducing agents such as dithiothreitol, GSH, cysteine, or 2-mercaptoethanol. The dimeric inhibitor (TPI-D) with an intermolecular disulfide bridge was also inactive and was converted to the active monomeric inhibitor on addition of dithiothreitol. TPI-2 is most likely a mixed disulfide with glutathione. One (Cys-3) of two cysteine residues exposed on the surface of the molecule of TPI-2 is involved in the formation of a mixed disulfide, and the other cysteine residue (Cys-64) is buried in the molecule. The activity of rat liver thiol proteinase inhibitor may possibly be regulated by formation of a protein mixed disulfide or by reduction of the mixed disulfide.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Di Giaimo, M. Riccio, S. Santi, C. Galeotti, D. C. Ambrosetti, and M. Melli New insights into the molecular basis of progressive myoclonus epilepsy: a multiprotein complex with cystatin B Hum. Mol. Genet., November 1, 2002; 11(23): 2941 - 2950. [Abstract] [Full Text] [PDF]

				E. Pol and I. Bjork Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases Protein Sci., September 1, 2001; 10(9): 1729 - 1738. [Abstract] [Full Text] [PDF]

				A. Rompel, R. M. Cinco, M. J. Latimer, A. E. McDermott, R. D. Guiles, A. Quintanilha, R. M. Krauss, K. Sauer, V. K. Yachandra, and M. P. Klein Sulfur K-edge x-ray absorption spectroscopy: A spectroscopic tool to examine the redox state of S-containing metabolites in vivo PNAS, May 26, 1998; 95(11): 6122 - 6127. [Abstract] [Full Text] [PDF]